Project Details
| Status | Active |
|---|---|
| Effective start/end date | 4/4/23 → 4/4/26 |
Funding
- INC Research, LLC (Prot #LP352-202 // Prot #LP352-202)
- Longboard Pharmaceuticals, Inc. (Prot #LP352-202 // Prot #LP352-202)
(OE) Prot #LP352-202: A Phase 2, Multicenter, Open-label, Long-term Safety Study of LP352 in Subjects with Developmental and Epileptic Encephalopathy Who Completed Study LP352-201 and Are Candidates for Continuous Treatment for up to 52 weeks
- Macken, Micheal P (PD/PI)
Project: Research project